Nicolas Willand

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Science (New York, N.Y.)

Science translational medicine

Université de Lille II

Université de Lille II (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Lille II

France

Full Professor :: Organic and Medicinal Chemistry

Education History

Université de Lille II

France

PHD :: Medicinal Chemistry

Université Lille 1

France

MSC :: Organic chemistry

Publications

Francesca Ruggieri, Philippe Hance, Bruna Gioia, Alexandre Biela, Pascal Roussel, Jean Louis Hilbert, Nicolas Willand
A Three-Step Process to Isolate Large Quantities of Bioactive Sesquiterpene Lactones from Cichorium intybus L. Roots and Semisynthesis of Chicory STLs Standards. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Bruna Gioia, Francesca Ruggieri, Alexandre Biela, Valérie Landry, Pascal Roussel, Catherine Piveteau, Florence Leroux, Ruben Christiaan Hartkoorn, Nicolas Willand
Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against Mycobacterium tuberculosis . International journal of molecular sciences 24 (24) (2023)
Salia Tangara, Léo Faïon, Catherine Piveteau, Frédéric Capet, Romain Godelier, Marion Michel, Marion Flipo, Benoit Déprez, Nicolas Willand, Baptiste Villemagne
Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers' Lactamization. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Léo Faïon, Kamel Djaout, Catalin Pintiala, Catherine Piveteau, Florence Leroux, Alexandre Biela, Stéphanie Slupek, Rudy Antoine, Monika Záhorszká, François-Xavier Cantrelle, Xavier Hanoulle, Jana Korduláková, Benoit Déprez, Nicolas Willand, Alain R Baulard, Marion Flipo
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Léo Faïon, Kamel Djaout, Catalin Pintiala, Catherine Piveteau, Florence Leroux, Alexandre Biela, Stéphanie Slupek, Rudy Antoine, Monika Záhorszká, François-Xavier Cantrelle, Xavier Hanoulle, Jana Korduláková, Benoit Déprez, Nicolas Willand, Alain R Baulard, Marion Flipo
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Salia Tangara, Léo Faïon, Catherine Piveteau, Frédéric Capet, Romain Godelier, Marion Michel, Marion Flipo, Benoit Déprez, Nicolas Willand, Baptiste Villemagne
Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers' Lactamization. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Léo Faïon, Kamel Djaout, Catalin Pintiala, Catherine Piveteau, Florence Leroux, Alexandre Biela, Stéphanie Slupek, Rudy Antoine, Monika Záhorszká, François-Xavier Cantrelle, Xavier Hanoulle, Jana Korduláková, Benoit Déprez, Nicolas Willand, Alain R Baulard, Marion Flipo
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Salia Tangara, Léo Faïon, Catherine Piveteau, Frédéric Capet, Romain Godelier, Marion Michel, Marion Flipo, Benoit Déprez, Nicolas Willand, Baptiste Villemagne
Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers' Lactamization. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Bruna Gioia, Francesca Ruggieri, Alexandre Biela, Valérie Landry, Pascal Roussel, Catherine Piveteau, Florence Leroux, Ruben Christiaan Hartkoorn, Nicolas Willand
Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against Mycobacterium tuberculosis . International journal of molecular sciences 24 (24) (2023)
Marion Flipo, Rosangela Frita, Marilyne Bourotte, María Santos Martínez, Markus Boesche, Gary W Boyle, Geo Derimanov, Gerard Drewes, Pablo Gamallo, Sonja Ghidelli-Disse, Stephanie Gresham, Elena Jiménez, Jaime de Mercado, Esther Pérez-Herrán, Esther Porras-De Francisco, Joaquín Rullas, Patricia Casado Castro, Florence Leroux, Catherine Piveteau, Mehdi Kiass, Vanessa Mathys, Karine Soetaert, Véronique Megalizzi, Abdalkarim Tanina, René Wintjens, Rudy Antoine, Priscille M Brodin, Vincent Delorme, Martin Moune, Kamel Djaout, Stéphanie Slupek, Christian Kemmer, Marc Gitzinger, Lluis Ballell, Alfonso Mendoza-Losana, Sergio Lociuro, Benoit Déprez, David Barros Aguirre, Modesto J Remuiñán, Nicolas Willand, Alain R Baulard
The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis. Science translational medicine 14 (643) (2022)
Nicolas Blondiaux, Martin Moune, Matthieu Desroses, Rosangela Frita, Marion Flipo, Vanessa Mathys, Karine Soetaert, Mehdi Kiass, Vincent Delorme, Kamel Djaout, Vincent Trebosc, Christian Kemmer, René Wintjens, Alexandre Wohlkönig, Rudy Antoine, Ludovic Huot, David Hot, Mireia Coscolla, Julia Feldmann Uhry, Sebastien Gagneux, Camille Locht, Priscille M Brodin, Marc Gitzinger, Benoit Déprez, Nicolas Willand, Alain R Baulard
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. Science (New York, N.Y.) 355 (6330) (2017)

Nicolas Willand.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicolas Willand